Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma

[1]  M. Mann,et al.  T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice. , 2015, Gastroenterology.

[2]  M. Plummer,et al.  World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma , 2015, Hepatology.

[3]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[4]  Sandrine Imbeaud,et al.  DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma , 2015, Hepatology.

[5]  B. Meléndez,et al.  Genome‐wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster , 2015, Genes, chromosomes & cancer.

[6]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[7]  A. Nogai,et al.  Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region , 2015, BMC Cancer.

[8]  Stephen W. Hartley,et al.  DNA methylome and transcriptome sequencing in human ovarian granulosa cells links age-related changes in gene expression to gene body methylation and 3ʹ-end GC density , 2015, Oncotarget.

[9]  Hui Zhang,et al.  MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration , 2014, Breast Cancer Research.

[10]  Gangning Liang,et al.  Gene body methylation can alter gene expression and is a therapeutic target in cancer. , 2014, Cancer cell.

[11]  U. Lehmann,et al.  DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[12]  Young-Joon Kim,et al.  HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators , 2014, Proceedings of the National Academy of Sciences.

[13]  Jacek Marzec,et al.  Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia. , 2014, Blood.

[14]  Jingde Zhu,et al.  Hepatitis virus infection affects DNA methylation in mice with humanized livers. , 2014, Gastroenterology.

[15]  Wei Li,et al.  Large conserved domains of low DNA methylation maintained by Dnmt3a , 2013, Nature Genetics.

[16]  Y. Osaki,et al.  Non-B, non-C hepatocellular carcinoma (Review). , 2013, International journal of oncology.

[17]  H. Asaoku,et al.  Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma , 2013, Genome Medicine.

[18]  G. Goodall,et al.  Identification of an Enhancer That Increases miR-200b~200a~429 Gene Expression in Breast Cancer Cells , 2013, PloS one.

[19]  K. Hui,et al.  MicroRNA‐216a/217‐induced epithelial‐mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer , 2013, Hepatology.

[20]  F. Jasmine,et al.  Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips , 2013, Epigenetics.

[21]  Alfonso Valencia,et al.  Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.

[22]  F. Cetani,et al.  The microRNA cluster C19MC is deregulated in parathyroid tumours. , 2012, Journal of molecular endocrinology.

[23]  Chien-Jen Chen,et al.  Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma , 2012, Epigenetics.

[24]  J. Bullerdiek,et al.  Exosome-delivered microRNAs of “chromosome 19 microRNA cluster” as immunomodulators in pregnancy and tumorigenesis , 2012, Molecular Cytogenetics.

[25]  Massimo Negrini,et al.  In hepatocellular carcinoma miR‐519d is up‐regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 , 2012, The Journal of pathology.

[26]  H. Saito,et al.  Role of CTCF in the regulation of microRNA expression , 2012, Front. Gene..

[27]  J. Byrd,et al.  Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. , 2012, Cancer research.

[28]  M. Imamura,et al.  Recent trend of clinical features in patients with hepatocellular carcinoma , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[30]  M. Taniai,et al.  Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey , 2011, Journal of Gastroenterology.

[31]  H. Asaoku,et al.  Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma , 2009, Clinical Cancer Research.

[32]  M. Toyota,et al.  Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer , 2007, Oncogene.

[33]  S Miyano,et al.  Open source clustering software. , 2004, Bioinformatics.

[34]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.